201 related articles for article (PubMed ID: 12368147)
1. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease].
Garcia J; Galinier A; Periquet B; Broué P; Decramer S; Thouvenot JP; Caspar-Bauguil S
Ann Biol Clin (Paris); 2002; 60(5):602-6. PubMed ID: 12368147
[No Abstract] [Full Text] [Related]
2. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
3. [Maple syrup urine disease and cystathioninemia].
Simma B; Sperl W; Berger H
Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
[TBL] [Abstract][Full Text] [Related]
4. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
Schuchmann L; Witt I; Schulz P; Schumacher H; Rüdiger H
Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280
[No Abstract] [Full Text] [Related]
5. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
[No Abstract] [Full Text] [Related]
6. A rapid ultra performance liquid chromatography tandem mass spectrometric method for measuring amino acids associated with maple syrup urine disease, tyrosinaemia and phenylketonuria.
Freeto S; Mason D; Chen J; Scott RH; Narayan SB; Bennett MJ
Ann Clin Biochem; 2007 Sep; 44(Pt 5):474-81. PubMed ID: 17761035
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
8. Maple syrup urine disease: emergency treatment of the neonate.
Hammersen G; Wille L; Schmidt H; Lutz P; Bickel H
Monogr Hum Genet; 1978; 9():84-9. PubMed ID: 104150
[No Abstract] [Full Text] [Related]
9. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
Allen RJ; Frey HJ; Fleming LM; Owings CL
Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
[No Abstract] [Full Text] [Related]
11. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
[No Abstract] [Full Text] [Related]
12. M aple syrup urine disease. A review with a report of an additional case.
Schwartz JF; Kolendrianos ET
Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
[No Abstract] [Full Text] [Related]
13. Outcome of early and long-term management of classical maple syrup urine disease.
Clow CL; Reade TM; Scriver CR
Pediatrics; 1981 Dec; 68(6):856-62. PubMed ID: 6798541
[TBL] [Abstract][Full Text] [Related]
14. [Maple syrup urine disease with an intermittent relatively benign course].
Müller H; Bickel H; Feist D; Lutz P
Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
[No Abstract] [Full Text] [Related]
15. Chromatographic diagnosis of maple syrup urine disease by measuring the L-alloisoleucine/L-phenylalanine ratio in dried blood spots.
Jeong JS; Sim HJ; Lee YM; Yoon HR; Kwon HJ; Hong SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2171-4. PubMed ID: 21680261
[TBL] [Abstract][Full Text] [Related]
16. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
[TBL] [Abstract][Full Text] [Related]
17. Maple syrup urine disease. Two cases in Israel.
Chemke J; Levin S
Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease: report of a case.
Rao GP; Ramanamurthy PS; Ghafoorunnisa ; Rafeeq MR; Pathak R
Indian Pediatr; 1974 Aug; 11(8):585-7. PubMed ID: 4443061
[No Abstract] [Full Text] [Related]
19. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
Jouvet P; Hubert P; Saudubray JM; Rabier D; Man NK
Pediatr Res; 2005 Aug; 58(2):278-82. PubMed ID: 16085796
[TBL] [Abstract][Full Text] [Related]
20. [Results of screening studies for phenylketonuria, maple syrup disease and homocystinuria using Guthrie's test].
Machill G
Kinderarztl Prax; 1973 May; 41(5):205-9. PubMed ID: 4732358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
